Nureca IPO Opens For Bidding. Here Are Key Things To Know
Nureca's Rs 100 crore public issue opened for subscription today i.e. February 15, 2021. The public offer of Nureca, which owns the Dr Trust brand, will remain open for three day until Wednesday i.e. February 18, 2021. The shares, which are being offered in the price band of Rs 396-400, are set to be listed on the BSE Sensex and NSE Nifty exchanges.
Bids can be placed for a minimum one lot of 35 equity shares and a maximum of 14 lots, or 490 shares. A total of up to 75 per cent of the issue will be reserved for qualified institutional buyers, up to 10 per cent for retail investors and the rest 15 per cent for the non-institutional category. The company employees are being offered a discount of Rs 20 per share.
Nureca will utilise the share proceeds to fund its incremental working capital requirements and for general corporate purposes.
Nureca raised Rs 44.55 crore from two anchor investors on Friday, February 12, 2021 at the upper price band of Rs 400 per share.
ITI Capital Ltd is the sole book running lead manager and Link Intime India Private is the registrar to the issue.
Nureca is a home healthcare and wellness products company that sells products through its own website and online channel partners such as e-commerce players, distributors and retailers. It also sells products through its website, drtrust.in.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
